文献速递肺栓塞与肺血管病

儿童肺动脉高压髋部加速度计测量的体力活动与疾病严重程度的关联及最小重要差异估计

Physical Activity Measured by Hip-Anchored Accelerometry in Pediatric Pulmonary Hypertension: Association With Disease Severity and Estimation of Minimal Important Differences.
PubMed 文献 · Chest · 2025-02-08

本研究分析54例血流动力学确诊的儿童肺动脉高压患者,评估髋部加速度计测量的体力活动(PA)与疾病严重程度指标的关联,并基于锚定法估计最小重要差异(MID)。结果显示PA指标与WHO功能分级、6分钟步行距离及NT-proBNP显著相关,并给出了对应不同锚定指标的MID z评分值。

要点

  • 儿童肺动脉高压中,加速度计测量的体力活动与疾病严重程度显著相关。
  • 基于6MWD和WHO-FC锚定的MID估计为0.3-0.7 CPM z评分和0.4-0.6 %MVPA z评分。
  • 髋部加速度计体力活动可作为儿童肺动脉高压试验的潜在终点指标。

核心结论

  • 儿童肺动脉高压中体力活动加速度计指标与疾病严重程度稳健相关,并提供了基于锚定的最小重要差异估计,填补了儿童肺动脉高压试验设计的空白。

研究设计与样本

  • 研究分析了54例血流动力学确诊的儿童肺动脉高压患者的加速度计数据,采用单变量线性回归和混合效应模型进行横断面和纵向分析。

主要发现

  • 横断面分析中,CPM z评分与WHO功能分级、6MWD z评分和NT-proBNP水平显著相关。
  • %MVPA z评分与WHO功能分级和6MWD z评分显著相关。
  • 纵向分析证实这些关联贯穿疾病全程。
  • 以6MWD z评分为锚定时,CPM z评分的平均MID为0.3至0.4,%MVPA z评分为0.4至0.5。
  • 以WHO功能分级为锚定时,CPM z评分的平均MID为0.7,%MVPA z评分为0.5至0.6。

临床怎么用

  • 髋部加速度计测量的体力活动可作为儿童肺动脉高压临床试验中评估疾病严重程度和治疗效果的潜在终点指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pediatric pulmonary hypertension (PH) is a severe incurable disease with a poor prognosis. In pediatric PH, trial design is hampered by the absence of age-appropriate trial end points. This study evaluated physical activity (PA) measured by hip-anchored accelerometry as a potential trial end point in pediatric PH. RESEARCH QUESTION: Is PA accelerometry associated with disease severity, and based on this association, what minimally important differences (MIDs) correspond to meaningful changes in disease severity in pediatric PH? STUDY DESIGN AND METHODS: Accelerometer outputs from 54 children with hemodynamically confirmed PH were analyzed. Univariable linear regression and mixed-effect models were used for cross-sectional and longitudinal analyses, respectively, (1) to evaluate the association between z scores of PA accelerometry counts per minute (CPMs) and of percentage of time spent in moderate to vigorous PA and disease severity indices 6-minute walk distance (6MWD) z scores, World Health Organization functional class (WHO-FC), N-terminal pro-B-type natriuretic peptide (NT-proBNP), and tricuspid annular plane systolic excursion z scores; and (2) to perform anchor-based MID estimations for CPMs and percentage of time spent in moderate to vigorous PA accelerometry intensity level (%MVPA) z scores, using defined clinical functional impairment levels (6MWD z scores and WHO-FC) as reference anchors. RESULTS: When assessing the association between disease severity and PA accelerometry cross-sectionally, we found significant associations between CPM z scores and WHO-FC, 6MWD z scores, and NT-proBNP levels. %MVPA z score was associated significantly with WHO-FC and 6MWD z score. In longitudinal analysis, these associations were confirmed throughout the disease course. MID estimations, expressed in z score units, resulted in mean MIDs of 0.3 to 0.4 CPM z score when anchored to 6MWD z scores, 0.7 CPM z score when anchored to WHO-FC, 0.4 to 0.5 %MVPA z score when anchored to 6MWD z scores, and 0.5 to 0.6 %MVPA z scores when anchored to WHO-FC. INTERPRETATION: This study underscored the robust relationship between PA accelerometry and disease severity in children with PH and fills a critical gap in pediatric PH trial design and evaluation of treatment efficacy by providing anchor-based MID estimates for hip-anchored PA accelerometry.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Ploegstra MJ, Ferreira RJ, Lokhorst C, et al. Physical Activity Measured by Hip-Anchored Accelerometry in Pediatric Pulmonary Hypertension: Association With Disease Severity and Estimation of Minimal Important Differences. Chest. 2025. PMID: 39929278. doi:10.1016/j.chest.2025.01.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。